Logo image of MND.CA

MANDALAY RESOURCES CORP (MND.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:MND - CA5625684025 - Common Stock

5.4 CAD
+0.29 (+5.68%)
Last: 8/6/2025, 7:00:00 PM
Fundamental Rating

7

MND gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 796 industry peers in the Metals & Mining industry. Both the health and profitability get an excellent rating, making MND a very profitable company, without any liquidiy or solvency issues. MND scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make MND a good candidate for value investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MND was profitable.
MND had a positive operating cash flow in the past year.
Each year in the past 5 years MND has been profitable.
MND had a positive operating cash flow in each of the past 5 years.
MND.CA Yearly Net Income VS EBIT VS OCF VS FCFMND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 15.21%, MND belongs to the best of the industry, outperforming 95.34% of the companies in the same industry.
With an excellent Return On Equity value of 22.08%, MND belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
MND has a better Return On Invested Capital (19.39%) than 97.73% of its industry peers.
MND had an Average Return On Invested Capital over the past 3 years of 11.24%. This is in line with the industry average of 12.63%.
The 3 year average ROIC (11.24%) for MND is below the current ROIC(19.39%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROIC 19.39%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
MND.CA Yearly ROA, ROE, ROICMND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With an excellent Profit Margin value of 21.54%, MND belongs to the best of the industry, outperforming 95.09% of the companies in the same industry.
In the last couple of years the Profit Margin of MND has declined.
With an excellent Operating Margin value of 37.25%, MND belongs to the best of the industry, outperforming 96.10% of the companies in the same industry.
In the last couple of years the Operating Margin of MND has grown nicely.
MND has a Gross Margin of 43.15%. This is amongst the best in the industry. MND outperforms 93.58% of its industry peers.
MND's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
MND.CA Yearly Profit, Operating, Gross MarginsMND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MND is creating value.
The number of shares outstanding for MND has been increased compared to 1 year ago.
Compared to 5 years ago, MND has more shares outstanding
The debt/assets ratio for MND has been reduced compared to a year ago.
MND.CA Yearly Shares OutstandingMND.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MND.CA Yearly Total Debt VS Total AssetsMND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MND has an Altman-Z score of 4.07. This indicates that MND is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MND (4.07) is better than 60.96% of its industry peers.
MND has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
MND's Debt to FCF ratio of 0.12 is amongst the best of the industry. MND outperforms 96.85% of its industry peers.
MND has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, MND is in line with its industry, outperforming 45.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Altman-Z 4.07
ROIC/WACC2.16
WACC8.96%
MND.CA Yearly LT Debt VS Equity VS FCFMND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

MND has a Current Ratio of 2.32. This indicates that MND is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.32, MND is in line with its industry, outperforming 57.43% of the companies in the same industry.
MND has a Quick Ratio of 1.93. This is a normal value and indicates that MND is financially healthy and should not expect problems in meeting its short term obligations.
MND's Quick ratio of 1.93 is in line compared to the rest of the industry. MND outperforms 56.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.93
MND.CA Yearly Current Assets VS Current LiabilitesMND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 370.59% over the past year.
Measured over the past years, MND shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.42% on average per year.
The Revenue has grown by 40.99% in the past year. This is a very strong growth!
Measured over the past years, MND shows a quite strong growth in Revenue. The Revenue has been growing by 17.42% on average per year.
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%

3.2 Future

MND is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.09% yearly.
The Revenue is expected to decrease by -1.40% on average over the next years.
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue Next Year10.01%
Revenue Next 2Y6.82%
Revenue Next 3Y0.03%
Revenue Next 5Y-1.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MND.CA Yearly Revenue VS EstimatesMND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
MND.CA Yearly EPS VS EstimatesMND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 -1

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.91 indicates a rather cheap valuation of MND.
Compared to the rest of the industry, the Price/Earnings ratio of MND indicates a rather cheap valuation: MND is cheaper than 97.48% of the companies listed in the same industry.
MND's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
MND is valuated cheaply with a Price/Forward Earnings ratio of 5.24.
Based on the Price/Forward Earnings ratio, MND is valued cheaply inside the industry as 96.22% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.22. MND is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.91
Fwd PE 5.24
MND.CA Price Earnings VS Forward Price EarningsMND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MND indicates a rather cheap valuation: MND is cheaper than 99.12% of the companies listed in the same industry.
98.61% of the companies in the same industry are more expensive than MND, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.88
EV/EBITDA 2.18
MND.CA Per share dataMND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MND does not grow enough to justify the current Price/Earnings ratio.
MND has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as MND's earnings are expected to decrease with -9.00% in the coming years.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y7.23%
EPS Next 3Y-9%

0

5. Dividend

5.1 Amount

MND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANDALAY RESOURCES CORP

TSX:MND (8/6/2025, 7:00:00 PM)

5.4

+0.29 (+5.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-05 2025-08-05
Earnings (Next)11-04 2025-11-04
Inst Owners49.88%
Inst Owner ChangeN/A
Ins Owners2.16%
Ins Owner ChangeN/A
Market Cap511.16M
Revenue(TTM)263.21M
Net Income(TTM)56.70M
Analysts80
Price Target7.14 (32.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.98%
Min EPS beat(2)-5.49%
Max EPS beat(2)41.44%
EPS beat(4)3
Avg EPS beat(4)58%
Min EPS beat(4)-5.49%
Max EPS beat(4)117.82%
EPS beat(8)5
Avg EPS beat(8)4.3%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.88%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)3.05%
Revenue beat(4)2
Avg Revenue beat(4)5.48%
Min Revenue beat(4)-2.25%
Max Revenue beat(4)22.41%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.45%
EPS NQ rev (1m)26.67%
EPS NQ rev (3m)18.75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.96%
Revenue NY rev (3m)5.96%
Valuation
Industry RankSector Rank
PE 4.91
Fwd PE 5.24
P/S 1.41
P/FCF 5.88
P/OCF 3.33
P/B 1.44
P/tB 1.44
EV/EBITDA 2.18
EPS(TTM)1.1
EY20.37%
EPS(NY)1.03
Fwd EY19.09%
FCF(TTM)0.92
FCFY17.02%
OCF(TTM)1.62
OCFY30%
SpS3.83
BVpS3.74
TBVpS3.74
PEG (NY)1.92
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROCE 31.66%
ROIC 19.39%
ROICexc 27.12%
ROICexgc 27.12%
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
FCFM 23.96%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
ROICexc(3y)14.44%
ROICexc(5y)16.27%
ROICexgc(3y)14.44%
ROICexgc(5y)16.27%
ROCE(3y)18.36%
ROCE(5y)21.62%
ROICexgc growth 3Y6.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y6.04%
ROICexc growth 5YN/A
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Debt/EBITDA 0.04
Cap/Depr 138.52%
Cap/Sales 18.28%
Interest Coverage 94.28
Cash Conversion 83.73%
Profit Quality 111.25%
Current Ratio 2.32
Quick Ratio 1.93
Altman-Z 4.07
F-Score9
WACC8.96%
ROIC/WACC2.16
Cap/Depr(3y)122.26%
Cap/Depr(5y)123.51%
Cap/Sales(3y)21.13%
Cap/Sales(5y)21.9%
Profit Quality(3y)111.23%
Profit Quality(5y)107.72%
High Growth Momentum
Growth
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%
Revenue Next Year10.01%
Revenue Next 2Y6.82%
Revenue Next 3Y0.03%
Revenue Next 5Y-1.4%
EBIT growth 1Y218.33%
EBIT growth 3Y5.22%
EBIT growth 5YN/A
EBIT Next Year39.15%
EBIT Next 3Y9.81%
EBIT Next 5Y0.91%
FCF growth 1Y363.77%
FCF growth 3Y69.59%
FCF growth 5YN/A
OCF growth 1Y112.12%
OCF growth 3Y22.03%
OCF growth 5Y71.54%

MANDALAY RESOURCES CORP / MND.CA FAQ

What is the fundamental rating for MND stock?

ChartMill assigns a fundamental rating of 7 / 10 to MND.CA.


What is the valuation status of MANDALAY RESOURCES CORP (MND.CA) stock?

ChartMill assigns a valuation rating of 8 / 10 to MANDALAY RESOURCES CORP (MND.CA). This can be considered as Undervalued.


What is the profitability of MND stock?

MANDALAY RESOURCES CORP (MND.CA) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for MND stock?

The Price/Earnings (PE) ratio for MANDALAY RESOURCES CORP (MND.CA) is 4.91 and the Price/Book (PB) ratio is 1.44.


How financially healthy is MANDALAY RESOURCES CORP?

The financial health rating of MANDALAY RESOURCES CORP (MND.CA) is 7 / 10.